Robert Hof joined InnoCore as Chief Executive Officer in June 2023. He is a seasoned Life Sciences executive, combining an excellent scientific background in development , manufacturing and business experience. Prior to joining InnoCore, Robert worked in various Executive and Senior Management roles in the pharmaceutical services industry with companies including Symeres, DSM Biologics (now ThermoFisher) and Pepscan (now Biosynth). He is also a Board member of the LIFE Cooperative and Advisory Board Member to iPsomics.